FDA Drug Recalls

Recalls / Class II

Class IID-0176-2024

Product

Donepezil HCl Tablets, 10 mg, 90 Tablets, Rx only, Distributed by: Solco Healthcare U.S. LLC, Hurracao, Puerto Rico 00791. NDC: 43547-276-09

Brand name
Donepezil Hydrochloride
Generic name
Donepezil Hydrochloride
Active ingredient
Donepezil Hydrochloride
Route
Oral
NDCs
43547-275, 43547-276
FDA application
ANDA200292
Affected lot / code info
Batch 17616

Why it was recalled

CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.

Recalling firm

Firm
CARDINAL HEALTHCARE
Manufacturer
Solco Healthcare US, LLC
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
7200 Cardinal Pl W, Dublin, Ohio 43017-1094

Distribution

Quantity
1 unit
Distribution pattern
Nationwide USA

Timeline

Recall initiated
2022-01-26
FDA classified
2023-12-26
Posted by FDA
2024-01-03
Terminated
2024-09-29
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0176-2024. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: Donepezil Hydrochloride · FDA Drug Recalls